Journal
TRENDS IN GENETICS
Volume 37, Issue 3, Pages 203-204Publisher
CELL PRESS
DOI: 10.1016/j.tig.2020.11.007
Keywords
-
Categories
Funding
- French Government (Agence Nationale de Recherche, ANR) [ANR11-LABX-0028-01, ANR-15-IDEX01, R19162DD]
- CANC'AIR Genexposomic project
- Canceropole ProvenceAlpes-Cote d'Azur (PACA)
- Direction Regionale de l'Environnement, de l'Amenagement, et du Logement (DREAL)-PACA
- Agence Regionale de Sante (ARS)PACA
- Institut National du Cancer (INCA) Plan Cancer
- Children Medical Safety Research Institute (CMSRI, Vaccinophagy project) [R17033DJA]
- Region Sud
- INSERM Cancer
Ask authors/readers for more resources
By utilizing CRISPR-based whole-genome screening, Daniloski and his colleagues have identified key cellular pathways associated with SARS-CoV-2 infectivity, potentially offering new or repurposed drugs for combating COVID-19.
To uncover the key cellular pathways associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infectivity, Daniloski and coworkers used CRISPR-based whole-genome screening. Their results could propose new or repositioned drugs for the ongoing fight against COVID-19.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
